Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape
- 14 July 2023
- journal article
- review article
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 91 (2) , 176-183
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Increased coexpression of c‐KIT and FLT3 receptors on myeloblasts: Independent predictor of poor outcome in pediatric acute myeloid leukemiaCytometry Part B: Clinical Cytometry, 2013
- FLT3-ITD Mutation in Relation to FLT3 Expression in Pediatric AML: A Prospective Study from IndiaPediatric Hematology and Oncology, 2013
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaBlood, 2012
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory LeukemiaJournal of Clinical Oncology, 2011
- Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupBlood, 2010
- Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell DepletionJournal of Molecular Biology, 2010
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabineInternational Journal of Cancer, 2008
- Apoptosis in cancerCarcinogenesis, 2000